Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8+ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington (Q68233234)
scientific article published on 01 June 1992
Language:
Current Data About Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8+ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington
(P31) (Q13442814)
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643151%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, September 22, 2019

(P50) (Q6503944)
(P1545) 10
(P1932) L. Corey
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643151
(P813) Thursday, October 20, 2022

(P304) 319-338
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643151%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, September 22, 2019

(P407) (Q1860)
(P248)
(P698) 1643151
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1643151
(P813) Thursday, October 20, 2022

(P433) 3
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643151%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, September 22, 2019

(P478) 3
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643151%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, September 22, 2019

(P577) Monday, June 1, 1992
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643151%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, September 22, 2019

(P921) (Q1427096)
(P887)

(Q72138716)
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643151
(P813) Thursday, October 20, 2022

(Q7162)
(P248)
(P356) 10.1089/HUM.1992.3.3-319
(P854) https://api.crossref.org/works/10.1089/HUM.1992.3.3-319
(P813) Thursday, October 20, 2022

(Q3523816)
(P248)
(P356) 10.1089/HUM.1992.3.3-319
(P854) https://api.crossref.org/works/10.1089/HUM.1992.3.3-319
(P813) Thursday, October 20, 2022

(P953) http://www.liebertpub.com/doi/pdf/10.1089/hum.1992.3.3-319
(P248)
(P356) 10.1089/HUM.1992.3.3-319
(P854) https://api.crossref.org/works/10.1089/HUM.1992.3.3-319
(P813) Thursday, October 20, 2022

(P1433) (Q15757580)
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643151%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, September 22, 2019

(P1476) "Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of Oncology" (language: en)
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1643151%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, September 22, 2019

"Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8+ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington" (language: en)
(P248)
(P356) 10.1089/HUM.1992.3.3-319
(P854) https://api.crossref.org/works/10.1089/HUM.1992.3.3-319
(P813) Thursday, October 20, 2022

(P2093) S. R. Riddell
(P1545) 1
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643151
(P813) Thursday, October 20, 2022

P. D. Greenberg
(P1545) 2
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643151
(P813) Thursday, October 20, 2022

R. W. Overell
(P1545) 3
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643151
(P813) Thursday, October 20, 2022

T. P. Loughran
(P1545) 4
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643151
(P813) Thursday, October 20, 2022

M. J. Gilbert
(P1545) 5
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643151
(P813) Thursday, October 20, 2022

S. D. Lupton
(P1545) 6
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643151
(P813) Thursday, October 20, 2022

J. Agosti
(P1545) 7
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643151
(P813) Thursday, October 20, 2022

S. Scheeler
(P1545) 8
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643151
(P813) Thursday, October 20, 2022

R. W. Coombs
(P1545) 9
(P248)
(P698) 1643151
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643151
(P813) Thursday, October 20, 2022

other details
description scientific article published on 01 June 1992

External Links
(P356) 10.1089/HUM.1992.3.3-319
(P698) 1643151